jeena sikho lifecare has announced the publication of two case studies authored by its research officers and professionals in the International Journal of Advanced Research (IJAR). The studies, authored by the Managing Director, senior consultants, and Ayurvedic experts, focus on the Ayurvedic management of kidney disorders. This initiative highlights the company's commitment to Ayurvedic research and evidence-based clinical practice.

The first case study, titled "Ayurvedic Management of Chronic Kidney Disease (Vrikka Vikara) with Reference to Mutravah Sroto Dushti: A Case Study," explores treatment methodologies for chronic kidney conditions. The second study, "Role of Ayurveda in The Management of Vrikka Vikar (Kidney Disorders): A Case Study," further examines the efficacy of Ayurvedic interventions for renal health issues.

Details of Published Case Studies

The disclosure was made to the National Stock Exchange of India Limited and BSE Limited on July 20, 2026, under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The information is also available on the company's official website.

Jeena Sikho Lifecare Ltd has approved the appointment of four new directors and a new company secretary to strengthen its leadership team. The decisions were taken during a board meeting held on July 15, 2026, pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Mrs. Smita Chaturvedi has resigned from her position as Company Secretary and Compliance Officer, a Key Managerial Personnel (KMP) role, effective the close of business hours on July 14, 2026. She tendered her resignation to pursue alternate career opportunities outside the organization. Consequently, the board appointed Ms. Priya Goyal (Membership No. ACS-71180) as the new Company Secretary and Compliance Officer as well as KMP with effect from July 15, 2026.

The board also approved the appointment of three additional independent directors. Mr. Ajay Sharma (DIN: 07671350) was appointed as an Additional Director in the Non-Executive Independent Category. Mrs. Sapna Singh (DIN: 11812894) was appointed as an Additional Director in the Non-Executive Women Independent Director category. Both appointments are effective July 15, 2026, and will continue until the conclusion of the next general meeting. Their tenures are proposed to be regularized for two consecutive years from July 15, 2026, to July 14, 2028, subject to shareholder approval.

In the executive category, the board appointed Dr. Ish Sharma (DIN: 11815526) and Mr. Ankush Kaushal (DIN: 03308862) as Additional Directors and Whole Time Directors (KMP). Their appointments are effective July 15, 2026, and will remain until the ensuing general meeting. The regularization of their roles as Whole Time Directors for a tenure of two years from July 15, 2026, to July 14, 2028, is subject to the approval of the shareholders.

Summary of Appointments

The company confirmed that none of the newly appointed directors are debarred from holding the office of director by any order passed by the Securities and Exchange Board of India or any other authority. The board meeting commenced at 3:30 P.M. IST and concluded at 4:30 P.M. IST.